Allergic contact dermatitis to topical antibiotics: Epidemiology, responsible allergens, and management

Journal of the American Academy of Dermatology

Volumn 58, Issue 1, 2008, Pages 1-21

  Gehrig, Kathryn A ^a   Warshaw, Erin M ^b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BACITRACIN ZINC; BETA LACTAM ANTIBIOTIC; BUTIROSIN; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLOXACILLIN; COLISTIN; FRAMYCETIN; GENTAMICIN; KANAMYCIN; NEOMYCIN; OXYTETRACYLINE CHLORIDE; PAROMOMYCIN; PENICILLIN G; PETROLATUM; POLYMYXIN; POLYMYXIN B; PRISTINAMYCIN; RIBOSTAMYCIN; SISOMICIN; STREPTOMYCIN; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRGINIAMYCIN;

AGE DISTRIBUTION; ALLERGY TEST; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PRURITUS; ATOPY; BACTERIAL INFECTION; CHRONIC VEIN INSUFFICIENCY; CONJUNCTIVITIS; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; EAR INFECTION; ECZEMA; EDEMA; ERYTHEMA; EXTERNAL OTITIS; EYE INFECTION; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; LEG EDEMA; LEG ULCER; MUCOSAL DISEASE; MYCOBACTERIOSIS; OCCUPATIONAL ECZEMA; OCCUPATIONAL HAZARD; PAPULE; PATCH TEST; POPULATION RISK; PRIORITY JOURNAL; PYODERMA; REVIEW; SENSITIZATION; SEX DIFFERENCE; SKIN ALLERGY; SKIN INFECTION; SKIN PRURITUS; SKIN ULCER; SURGICAL WOUND; TREATMENT OUTCOME; TUBERCULOSIS; URTICARIA; VAGINITIS; VESICULAR RASH;

ADMINISTRATION, TOPICAL; AGE DISTRIBUTION; ALLERGENS; ANTI-BACTERIAL AGENTS; CROSS REACTIONS; DERMATITIS, ALLERGIC CONTACT; HUMANS; IMMUNOLOGIC TESTS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 37349040034     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.07.050     Document Type: Review

References (196)

1. Nethercott J.R., Holness D.L., Adams R.M., Belsito D.V., De Leo V.A., Emmett E.A., et al. Patch testing with a routine screening tray in North America, 1985 through 1989: frequency of response. Am J Contact Dermat 2 (1991) 122-129
2. Marks Jr. J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group standard tray patch test results (1992-1994). Am J Contact Dermat 6 (1995) 160-165
3. Marks Jr. J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 38 (1998) 911-918
4. Marks Jr. J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group Patch-Test Results, 1996-1998. Arch Dermatol 136 (2000) 272-273
5. Marks Jr. J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group patch test results, 1998-2000. Am J Contact Dermat 14 (2003) 59-62
6. Pratt M.D., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group Patch-Test Results, 2001-2002 Study Period. Dermatitis 15 (2004) 176-183
7. Prystowsky S.D., Allen A.M., Smith R.W., Nonomura J.H., Odom R.B., and Akers W.A. Allergic contact hypersensitivity to nickel, neomycin, ethylenediamine, and benzocaine. Arch Dermatol 115 (1979) 959-962
8. Nielsen N.H., and Menne T. Allergic contact sensitization in an unselected Danish population. Acta Derm Venereol 72 (1992) 456-460
9. Nethercott J.R., Holness D.L., Adams R.M., Belsito D.V., De Leo V.A., Emmett E.A., et al. Patch testing with a routine screening tray in North America, 1985-1989: gender and response. Am J Contact Dermat 2 (1991) 130-134
10. Menezes de Pádua C.A., Schnuch A., Lessmann H., Geier J., Pfahlberg A., and Uter W. Contact allergy to neomycin sulfate: results of a multifactorial analysis. Pharmacoepidemiol Drug Saf 14 (2005) 725-733
11. Green C.M., Holden C.R., and Gawkrodger D.J. Contact allergy to topical medicaments becomes more common with advancing age: an age-stratified study. Contact Dermatitis 56 (2007) 229-231
12. Nethercott J.R., Holness D.L., Adams R.M., Belsito D.V., De Leo V.A., Emmett E.A., et al. Multivariate analysis of the effect of selected factors on elicitation of patch test response to 28 common environmental contactants in North America. Am J Contact Dermat 5 (1994) 13-18
13. DeLeo V.A., Taylor S.C., Belsito D.V., Fowler J.F., Fransway A.F., Maibach H.I., et al. The effect of race and ethnicity on patch test results. J Am Acad Dermatol 46 suppl 2 (2002) 107-112
14. Kligman A.M. The identification of contact allergens by human assay. III. The maximization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol 47 (1966) 393-409
15. Saap L., Fahim S., Arsenault E., Pratt M., Pierscianowski T., Falanga V., et al. Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol 140 (2004) 1241-1246
16. Breit R. Drug contact allergy in eczema and ulcer of the leg. Munch Med Wochenschr 114 (1972) 22-27
17. Malten K.E., Kuiper J.P., and von der Staak W.B.J.M. Contact allergic investigations in 100 patients with ulcus cruris. Dermatologica 147 (1973) 241-254
18. Rudzki E., and Baranowska E. Contact sensitivity in stasis dermatitis. Dermatologica 148 (1974) 353-356
19. Angelini G., Rantuccio F., and Meneghini C.L. Contact dermatitis in patients with leg ulcers. Contact Dermatitis 1 (1975) 81-87
20. Breit R. Allergen change in stasis dermatitis. Contact Dermatitis 3 (1977) 309-311
21. Blondeel A., Oleffe J., and Achten G. Contact allergy in 330 dermatological patients. Contact Dermatitis 4 (1978) 270-276
22. Dooms-Goossens A., Degreef H., Parijs M., and Kerkhofs L. A retrospective study of patch test results from 163 patients with stasis dermatitis or leg ulcers. Dermatologica 159 (1979) 93-100
23. Fraki J.E., Peltonen L., and Hopsu-Havu V.K. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis 5 (1979) 97-100
24. Angelini G., Vena G.A., and Meneghini C.L. Allergic contact dermatitis to some medicaments. Contact Dermatitis 12 (1985) 263-269
25. Paramsothy Y., Collins M., and Smith A.G. Contact dermatitis in patients with leg ulcers. Contact Dermatitis 18 (1988) 30-36
26. Shupp D.L., and Winkelmann R.K. The role of patch testing in stasis dermatitis. Cutis 42 (1988) 528-530
27. Wilson C.L., Cameron J., Powell S.M., Cherry G., and Ryan T.J. High incidence of contact dermatitis in leg-ulcer patients-implication for management. Clin Exp Dermatol 16 (1991) 250-253
28. Zaki I., Shall L., and Dalziel K.L. Bacitracin: a significant sensitizer in leg ulcer patients?. Contact Dermatitis 31 (1994) 92-94
29. Rudzki E., and Rebandel P. Sensitivity to oxytetracycline. Contact Dermatitis 37 (1997) 136
30. Gallenkemper G., Rabe E., and Bauer R. Contact sensitization in chronic venous insufficiency: modern wound dressings. Contact Dermatitis 38 (1998) 274-278
31. Le Coz C.J., Scrivener Y., Santinelli F., and Heid E. Contact sensitization in leg ulcers. Ann Dermatol Venereol 125 (1998) 694-699
32. Perrenoud D., and Ramelet A. Chronic leg ulcers and eczema. Curr Probl Dermatol 27 (1999) 165-169
33. Holmes R.C., Johns A.N., Wilkinson J.D., Black M.M., and Rycroft R.J. Medicament contact dermatitis in patients with chronic inflammatory ear disease. J R Soc Med 75 (1982) 27-30
34. Fraki J.E., Kalimo K., Tuohimaa P., and Aantaa E. Contact allergy to various components of topical preparations for treatment of external otitis. Acta Octolaryngol (Stockh) 100 (1985) 414-418
35. Lembo G., Nappa P., Balato N., Pucci V., and Ayala F. Contact sensitivity in otitis externa. Contact Dermatitis 19 (1988) 64-65
36. Pigatto P.D., Bigardi A., Legori A., Altomare G., and Troiano L. Allergic contact dermatitis prevalence in patients with otitis externa. Acta Derm Venereol 71 (1991) 162-165
37. Onder M., Onder T., Ozünlü A., Makki S.S., and Gürer M.A. An investigation of contact dermatitis in patients with chronic otitis externa. Contact Dermatitis 31 (1994) 116-117
38. Devos S.A., Mulder J.J.S., and Van Der Valk P.G.M. The relevance of positive patch test reactions in chronic otitis externa. Contact Dermatitis 42 (2000) 354-355
39. Patrick J., Panzer J.D., and Derbes V.J. Neomycin sensitivity in the normal (nonatopic) individual. Arch Dermatol 102 (1970) 532-535
40. Epstein S. Neomycin sensitivity and atopy. Dermatologica 130 (1965) 280-286
41. Wereide K. Neomycin sensitivity in atopic dermatitis and other eczematous conditions. Acta Derm Venereol 50 (1970) 114-116
42. Cooper S.M., and Shaw S. Eyelid dermatitis: an evaluation of 232 patch test patients over 5 years. Contact Dermatitis 42 (2000) 291-293
43. Sherertz E.F. Chronic finger dermatitis after trauma. Diagnosis: posttraumatic eczema with allergic contact dermatitis to neomycin, bacitracin, and topical corticosteroids. Arch Dermatol 132 (1996) 461
44. Gette M.T., Marks J.G., and Maloney M.E. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 128 (1992) 365-367
45. Rudzki E., and Rebendel P. Contact sensitivity to antibiotics. Contact Dermatitis 11 (1984) 41-42
46. Sood A., and Taylor J.S. Bacitracin: allergen of the year. Am J Contact Dermat 14 (2003) 3-4
47. In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., and Katz S. (Eds). Fitzpatrick's dermatology in general medicine. 6th ed. (2003), McGraw-Hill, New York 1164-1177
48. In: O'Neil M.J., Smith A., Heckelman P.E., Gallipeau J.R., D'Arecca M.A., and Obenchain J.R. (Eds). The Merck index. 13th ed. (2001), Merck & Co, Inc., Whitehouse Station
49. Schorr W.F., Wenzel F.J., and Hegedus S.I. Cross-sensitivity and aminoglycoside antibiotics. Arch Dermatol 107 (1973) 533-539
50. Schorr W.F., and Ridgway H.B. Tobramycin-neomycin cross-sensitivity. Contact Dermatitis 3 (1977) 133-137
51. Kimura M., and Kawada A. Contact sensitivity induced by neomycin with cross-sensitivity to other aminoglycoside antibiotics. Contact Dermatitis 39 (1998) 148-150
52. In: McEvoy G.K., Snow E.K., Kester L., Miller J., Welsh O.H., and Litvak K. (Eds). AHFS Drug Information 2005 (2005), American Society of Health-System Pharmacists, Inc., Bethesda, MD
53. Physicians' desk reference. 59th ed. (2005), Thomson PDR, Montvale, NJ
54. Kaye E.T. Topical antibacterial agents. Infect Dis Clin North Am 14 (2000) 321-339
55. Leyden J.J., and Kligman A.M. Rationale for topical antibiotics. Cutis 22 (1978) 515-527
56. Lynfield Y.L. Allergic contact sensitization to gentamicin. N Y State J Med 70 (1970) 2235-2236
57. Sanchez-Perez J., Lopez M.P., Moreno de Vega Haro M.J., and Garcia-Diez A. Allergic contact dermatitis from gentamicin in eyedrops, with cross-reactivity to kanamycin but not neomycin. Contact Dermatitis 44 (2001) 54
58. Strauss M.J., and Warring F.C. Contact dermatitis from streptomycin. J Invest Dermatol 9 (1947) 3
59. Gauchía R., Rodríguez-Serna M., Silvestre J.F., Linana J.J., and Aliaga A. Allergic contact dermatitis from streptomycin in a cattle breeder. Contact Dermatitis 35 (1996) 374
60. Epstein S., and Wenzel F. Cross-sensitivity to various "mycins.". Arch Dermatol 86 (1962) 183-191
61. Jerez J., Rodriguez F., Jimenez J., and Martin-Gil D. Cross-reactions between aminoside antibiotics. Contact Dermatitis 17 (1987) 325
62. Rudzki E., and Rebandel P. Cross-reactions with 4 aminoglycoside antibiotics at various concentrations. Contact Dermatitis 35 (1996) 62
63. Pirilä V., and Rouhunkoski S. The pattern of cross-sensitivity to neomycin: fifty-one cases of secondary sensitization to paromomycin humatin. Dermatologica 125 (1962) 273-278
64. Pirilä V., and Rouhunkoski S. On cross-sensitization between neomycin, bacitracin, kanamycin and framycetin. Dermatologica 121 (1960) 335-341
65. Carruthers J.A., and Cronin E. Incidence of neomycin and framycetin sensitivity. Contact Dermatitis 2 (1976) 269-270
66. Pirilä V., Hirvonen M.L., and Rouhunkoski S. The pattern of cross-sensitivity to neomycin. Dermatologica 136 (1968) 321-324
67. Rudzki E., Zakrzewski Z., Rebandel P., Grzywa Z., and Hudymowicz W. Cross reactions between aminoglycoside antibiotics. Contact Dermatitis 18 (1988) 314-316
68. Menéndez Ramos F., Llamas Martín R., Zarco Olivo C., Dorado Bris J.M., and Merino Luque M.V. Allergic contact dermatitis from tobramycin. Contact Dermatitis 22 (1990) 305-306
69. Katz B.E., and Fisher A.A. Bacitracin: a unique topical antibiotic sensitizer. J Am Acad Dermatol 17 (1987) 1016-1024
70. Bjorkner B., and Möller H. Bacitracin: a cutaneous allergen and histamine liberator. Acta Dermatovener (Stockh) 53 (1973) 487-492
71. Pirilä V., Forstrom L., and Rouhunkoski S. Twelve years of sensitization to neomycin in Finland. Arch Derm Venereol 47 (1967) 419-425
72. Epstein S., and Wenzel F.J. Sensitivity to neomycin and bacitracin: cross-sensitization by coincidence?. Acta Derm Venereol 43 (1963) 1
73. Binnick A.N., and Clendenning W.E. Bacitracin contact dermatitis. Contact Dermatitis 4 (1978) 180-181
74. Held J.L., Kalb R.E., Ruszkowski A.M., and DeLeo V. Allergic contact dermatitis from bacitracin. J Am Acad Dermatol 17 (1987) 592-594
75. Saripalli Y.V., Achen F., and Belsito D.V. The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J Am Acad Dermatol 49 (2003) 65-69
76. Goh C.L. Contact sensitivity to topical antimicrobials. II. Sensitizing potentials of some topical antimicrobials. Contact Dermatitis 21 (1989) 166-171
77. Möller H. Eczematous contact allergy to oxytetracycline and polymyxin B. Contact Dermatitis 2 (1976) 289-290
78. Van Ketel W.G. Polymixine 8-sulfate and bacitracin. Contact Dermat 15 (1974) 445
79. Fisher A.A. Adverse reactions to bacitracin, polymyxin, and gentamicin sulfate. Cutis 32 (1983) 510-512
80. Bleumink E., and Nater J.P. Allergic contact dermatitis to virginiamycin. Dermatologica 144 (1972) 253-256
81. Tennstedt D., Dumont-Fruytier M., and Lachapelle J.M. Occupational allergic contact dermatitis to virginiamycin, an antibiotic used as a food additive for pigs and poultry. Contact Dermatitis 4 (1978) 133-134
82. Baes H. Allergic contact dermatitis to virginiamycin. Dermatologica 149 (1974) 231-235
83. Lachapelle J.M., and Lamy F. On allergic contact dermatitis to virginiamycin. Dermatologica 146 (1973) 320-322
84. Vickers H.R. Contact dermatitis caused by penicillin. Lancet 250 (1946) 307-308
85. Girard J.P. Recurrent angioneurotic oedema and contact dermatitis due to penicillin. Contact Dermatitis 4 (1978) 309
86. Fisher A.A. Allergic contact dermatitis to penicillin and streptomycin. Cutis 32 (1983) 314-318
87. Caplan R.M. Cutaneous hazards posed by agricultural chemicals. J Iowa Med Soc 59 (1969) 295-299
88. Rudzki E., Rebandel P., and Hudymowicz W. Decrease in frequency of occupational contact sensitivity to penicillin among nurses in Warsaw. Contact Dermatitis 41 (1999) 114
89. Nagreh D.S. Contact dermatitis from proprietary preparations in Malaysia. Int J Dermatol 15 (1976) 34
90. Gamboa P., Jauregui I., Urrutia I., et al. Contact sensitization to cloxacillin with oral tolerance to other β-lactam antibiotics. Contact Dermatitis 34 (1996) 75
91. Rietschel R.L., and Fowler Jr. J.F. Reactions to Topical Antimicrobials. In: Rietschel R.L., and Fowler Jr. J.F. (Eds). Fisher's contact dermatitis. 5th ed. (2001), Williams & Wilkins, Philadelphia, PA 167-184
92. Schulz K.H., Schopf E., and Wex O. Allergic occupational eczemas caused by ampicillin. Berufsdermatosen 18 (1970) 132-143
93. Häusermann P., and Bircher A.J. Immediate and delayed hypersensitivity to ceftriaxone, and anaphylaxis due to intradermal testing with other β-lactam antibiotics, in a previously amoxicillin-sensitized patient. Contact Dermatitis 47 (2002) 311-312
94. Foti C., Bonamonte D., Trenti R., Veña G.A., and Angelini G. Occupational contact allergy to cephalosporins. Contact Dermatitis 36 (1997) 104-105
95. Conde-Salazar L., Guimaraens D., Romero L.V., and Gonzalez M.A. Occupational dermatitis from cephalosporins. Contact Dermatitis 14 (1985) 70-71
96. Filipe P., Silva R., Almeida S., and Rodrigo F.G. Occupational allergic contact dermatitis from cephalosporins. Contact Dermatitis 34 (1996) 226
97. Foti C., Vena G.A., Cucurachi M.R., and Angelini G. Occupational contact allergy from cephalosporins. Contact Dermatitis 31 (1994) 129-130
98. Garcia F., Juste S., Garces M.M., Carretero P., Blanco J., Herrero D., et al. Occupational allergic contact dermatitis from ceftiofur without cross-sensitivity. Contact Dermatitis 39 (1998) 260
99. Milligan A., and Douglas W.S. Contact dermatitis to cephalexin. Contact Dermatitis 15 (1986) 91
100. Valsecchi R., Serra M., Pansera B., Foiadelli L., and Cainelli T. Patch testing in adverse drug reactions to penicillin and cephalosporin. Contact Dermatitis 7 (1981) 158
101. Van Ketel W.G. Immediate- and delayed-type allergy to erythromycin. Contact Dermatitis 2 (1976) 363-364
102. Lombardi P., Campolmo P., Spallanzani P., and Sertoli A. Delayed hypersensitivity to erythromycin. Contact Dermatitis 8 (1982) 416
103. Bernstein S.C., and Roenigk R.K. Surgical pearl: erythromycin ointment for topical antibiotic wound care. J Am Acad Dermatol 32 (1995) 659-660
104. Fisher A.A. The safety of topical erythromycin. Contact Dermatitis 2 (1976) 43-44
105. Martins C., Freitas J.D., Goncalo M., and Goncalo S. Allergic contact dermatitis from erythromycin. Contact Dermatitis 33 (1995) 360
106. Valsecchi R., Pansera B., and Reseghetti A. Contact allergy to erythromycin. Contact Dermatitis 34 (1996) 428
107. Fernandez Redondo V., Casas L., Taboada M., and Toribio J. Systemic contact dermatitis from erythromycin. Contact Dermatitis 30 (1994) 43-44
108. Minciullo P.L., Patafi M., Giannetto L., Ferlazzo B., Trombetta D., Saija A., et al. Allergic contact angioedema to benzoyl peroxide. J Clin Pharm Ther 31 (2006) 385-387
109. Dejobert Y., Martin P., Piette F., Thomas P., and Bergoend H. Contact dermatitis caused by benzoyl peroxide in podiatrists. Contact Dermatitis 40 (1999) 163
110. Lindemayr H., and Drobil M. Contact sensitization to benzoyl peroxide. Contact Dermatitis 7 (1981) 137-140
111. Vena G.A., Angelini G., and Meneghini C.L. Contact dermatitis to benzoyl peroxide. Contact Dermatitis 8 (1982) 338
112. Agathos M., and Bandmann H.-J. Benzoyl peroxide contact allergy in leg ulcer patients. Contact Dermatitis 11 (1984) 316-317
113. Forschner K., Zuberbier T., and Worm M. Benzoyl peroxide as a cause of airborne contact dermatitis in an orthopaedic technician. Contact Dermatitis 47 (2002) 241
114. Bonnekoh B., and Merk H.F. Airborne allergic contact dermatitis from benzoyl peroxide as a bleaching agent of candle wax. Contact Dermatitis 24 (1991) 367-368
115. Quirce S., Olaguibel J.M., Garcia B.E., and Tabar A.I. Occupational airborne contact dermatitis due to benzoyl peroxide. Contact Dermatitis 29 (1993) 165-166
116. Greiner D., Weber J., Kaufmann R., and Boehncke W.-H. Benzoyl peroxide as a contact allergen in adhesive tape. Contact Dermatitis 41 (1999) 233
117. Tsovilis E., Crepy M.-N., Jonathan A.-M., and Ameille J. Occupational contact dermatitis due to a marbler's exposure to benzoyl peroxide. Contact Dermatitis 52 (2005) 117-118
118. Azurdia R.M., and King C.M. Allergic contact dermatitis due to phenol-formaldehyde resin and benzoyl peroxide in swimming goggles. Contact Dermatitis 38 (1998) 234
119. Dejobert Y., Piette F., and Thomas P. Contact dermatitis from benzoyl peroxide in dental prostheses. Contact Dermatitis 46 (2002) 177-178
120. Kasten M.J. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc 74 (1999) 825-833
121. Urrutia I., Audícana M., Echechipía S., Gastaminza G., Bernaola G., and Fernández de Corrès L. Sensitization to chloramphenicol. Contact Dermatitis 26 (1992) 66
122. Van Joost T., Dikland W., Stolz E., and Prens E. Sensitization to chloramphenicol; a persistent problem. Contact Dermatitis 14 (1986) 176-178
123. Moyano J.C., Alvarez M., Fonseca J.L., Bellido J., and Munoz Bellido F.J. Allergic contact dermatitis to chloramphenicol. Allergy 51 (1996) 67-69
124. Vincenzi C., Morelli R., Bardazzi F., and Guerra L. Contact dermatitis from chloramphenicol in a leg ulcer cream. Contact Dermatitis 25 (1991) 64-65
125. Le Coz C.J., and Santinelli F. Facial contact dermatitis from chloramphenicol with cross-sensitivity to thiamphenicol. Contact Dermatitis 38 (1998) 108-109
126. Rebandel P., and Rudzki E. Occupational contact sensitivity in oculists. Contact Dermatitis 15 (1986) 92
127. Kubo Y., Nonaka S., and Yoshida H. Contact sensitivity to chloramphenicol. Contact Dermatitis 17 (1987) 245-247
128. Conde-Salazar L., Guimaraens D., and Romero L.V. Contact dermatitis from clindamycin. Contact Dermatitis 9 (1983) 225
129. Coskey R.J. Contact dermatitis due to clindamycin. Arch Dermatol 114 (1978) 446
130. Vejlstrup E., and Menné T. Contact dermatitis from clindamycin. Contact Dermatitis 32 (1995) 110
131. Yokoyama R., Mizuno E., Takeuchi M., Abe M., and Ueda H. Contact dermatitis due to clindamycin. Contact Dermatitis 25 (1991) 125
132. Micromedex Healthcare Series. Drugdex evaluations. Keyword search "clioquinol." Available at: http://dewey.lib.umn.edu:7040/hcs/librarian/ND_PR/Main/SBK/2/PFPUI/dV48mV1S2GCAK/ND_PG/PRIH/CS/3FA545/ND_T/HCS/ND_P/Main/DUPLICATIONSHIELDSYNC/BAEACA/ND_B/HCS/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/1092/ContentSetId/31/SearchTerm/clioquinol%20/SearchOption/BeginWith. Accessed May 20, 2007.
133. Lazarov A. European standard series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004. Contact Dermatitis 55 (2006) 73-76
134. Morris S.D., Rycroft R.J., White I.R., Wakelin S.H., and McFadden J.P. Comparative frequency of patch test reactions to topical antibiotics. Br J Dermatol 146 (2002) 1047-1051
135. Agner T., and Menné T. Sensitivity to clioquinol and chlorquinaldol in the quinoline mix. Contact Dermatitis 29 (1993) 163
136. Rodríguez A., Cabrerizo S., Barranco R., de Frutos C., and de Barrio M. Contact cross-sensitization among quinolines. Allergy 56 (2001) 795
137. Kernekamp A.S., and van Ketel W.G. Persistence of patch test reactions to clioquinol (Vioform) and cross-sensitization. Contact Dermatitis 6 (1980) 455-460
138. van Ketel W.G. Cross-sensitization to 5,7 dibromo-8-hydroxy-quinolone (DBO). Contact Dermatitis 1 (1975) 385
139. De Groot A.C. Contact allergy to sodium fusidate. Contact Dermatitis 8 (1982) 429
140. Verbov J.L. Sensitivity to sodium fusidate. Contact Dermatitis 7 (1970) 153
141. Cronin E. Contact dermatitis (1980), Churchill Livingstone, Edinburgh p. 208
142. Dave V.K., and Main R.A. Contact sensitivity to sodium fusidate. Contact Dermatitis 14 (1973) 398
143. Riess C.E., and Bruckner-Tuderman L. Delayed-type hypersensitivity to fusidic acid in patients with chronic dermatitis. Lancet 335 (1990) 1525-1526
144. Kuzolik M., Powell S.M., Cherry G., and Ryan T.J. Contact sensitivity in community-based leg ulcer patients. Clin Exp Dermatol 13 (1988) 82-84
145. Beutner K.R., Lemke S., and Calvarese B. A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential. Cutis 77 (2006) 12-17
146. Jappe U., Schnuch A., and Uter W. Rosacea and contact allergy to cosmetics and topical medicaments-retrospective analysis of multicentre surveillance data 1995-2002. Contact Dermatitis 52 (2005) 96-101
147. Vincenzi C., Lucente P., Ricci C., and Tosti A. Facial contact dermatitis due to metronidazole. Contact Dermatitis 36 (1997) 116-117
148. Wolf R., Orion E., and Matz H. Co-existing sensitivity to metronidazole and isothiazolinone. Clin Exp Dermatol 28 (2003) 506-507
149. Hausen B.M., Heesch B., and Kiel U. Studies on the sensitizing capacity of imidazole derivatives. Am J Contact Dermat 1 (1990) 25-33
150. Izu R., Aguirre A., Gonzalez M., and Diaz-Perez J.L. Contact dermatitis from tioconazole with cross-sensitivity to other imidazoles. Contact Dermatitis 26 (1992) 130-131
151. Eedy D.J. Mupirocin allergy in the setting of venous ulceration. Contact Dermatitis 32 (1995) 240-241
152. Zappi E.G., and Brancaccio R.R. Allergic contact dermatitis from mupirocin ointment. J Am Acad Dermatol 36 (1997) 266
153. Leyden J.J. Studies on the safety of Bactroban ointment: potential for contact allergy, contact irritation, phototoxicity and photo-allergy. Excerpta Med 16 (1985) 68-71
154. Conde-Salazar L., Guimaraens D., Gonzalez M.A., and Molina A. Occupational allergic contact dermatitis from nitrofurazone. Contact Dermatitis 32 (1995) 307-308
155. Downing J.G., and Brecker F.W. Further studies in the use of furacin in dermatology. N Engl J Med 239 (1948) 862-864
156. Ballmer-Weber B.K., and Elsner P. Contact allergy to nitrofurazone. Contact Dermatitis 31 (1994) 274-275
157. Bajaj A.K., and Gupta S.C. Contact hypersensitivity to topical antibacterial agents. Int J Dermatol 25 (1986) 103-105
158. Hull P.R., and De Beer H.A. Topical nitrofurazone, a potent sensitizer of the skin and mucosae. S Afr Med J 52 (1977) 189-190
159. Neldner K.H. Contact dermatitis from animal feed additives. Arch Dermatol 106 (1972) 722-723
160. García F., Blanco J., Carretero P., Herrero D., Juste S., Garcés M., et al. Anaphylactic reactions to topical rifamycin. Allergy 54 (1999) 527-528
161. Riboldi A., Pigatto P.D., Morelli M., Altomare G.F., and Polenghi M.M. Allergy to mercurochrome and rifamycin. Contact Dermatitis 12 (1985) 180
162. Guerra L., Adamo F., Venturo N., and Tardio M. Contact dermatitis due to rifamycin. Contact Dermatitis 25 (1991) 328
163. Milpied B., Van Wassenhove L., Larousse C., and Barriere H. Contact dermatitis from rifamycin. Contact Dermatitis 14 (1986) 252-253
164. Balato N., Lembo G., Patruno G., and Ayala F. Allergic contact dermatitis from rifamycin. Contact Dermatitis 19 (1988) 310
165. Bojs G., and Möller H. Eczematous contact allergy to oxytetracycline with cross-sensitivity to other tetracyclines. Berufsdermatosen 22 (1974) 202-208
166. Fisher A.A., and Adams R.M. Alternative for sensitizing neomycin topical medicaments. Cutis 28 (1981) 491-503
167. Grandinetti P.J., and Fowler Jr. J.F. Simultaneous contact allergy to neomycin, bacitracin, and polymyxin. J Am Acad Dermatol 23 (1990) 646-647
168. Comaish J.S., and Cunliffe W.J. Absorption of drugs from varicose ulcers: a cause of anaphylaxis. Br J Clin Pract 21 (1967) 97
169. Dyck E.D., and Vadas P. Anaphylaxis to topical bacitracin. Allergy 52 (1997) 870-871
170. Roupe G., and Strannegard O. Anaphylactic shock elicited by topical administration of bacitracin. Arch Dermatol 100 (1969) 450-452
171. Schechter J.F., Wilkinson R.D., and Del Carpio J. Anaphylaxis following the use of bacitracin ointment. Arch Dermatol 120 (1984) 909-911
172. Sarayan J.A., Dammin T.C., and Bouras A.E. Anaphylaxis to topical bacitracin-zinc ointment. Am J Emerg Med 16 (1998) 512-513
173. Blas M., Briesacher K.S., and Lobato E.B. Bacitracin irrigation: a cause of anaphylaxis in the operating room. Anesth Analg 91 (2000) 1027-1028
174. Sprung J., Schedewie H.K., and Kampine J.P. Intraoperative anaphylactic shock after bacitracin irrigation. Anesth Analg 71 (1990) 430-433
175. Goh C.L. Anaphylaxis from topical neomycin and bacitracin. Australas J Dermatol 27 (1986) 125-126
176. Eedy D.J., McMillan J.C., and Bingham E.A. Anaphylactic reactions to topical antibiotic combinations. Postgrad Med J 66 (1990) 858-859
177. Chiba Y., Takahashi S., Yamakawa Y., Aihara M., and Ikezawa Z. Contact urticaria syndrome caused by patch testing with cefotiam hydrochloride. Contact Dermatitis 41 (1999) 234
178. Schewach-Millet M., and Shpiro D. Urticaria and angioedema due to topically applied chloramphenicol ointment. Arch Dermatol 121 (1985) 587
179. Van Ketel W.G. Immediate- and delayed-type allergy to erythromycin. Contact Dermatitis 2 (1976) 363-364
180. Agathos M. Anaphylactic reaction to framycetin (neomycin B) and lignocaine. Contact Dermatitis 6 (1980) 236-237
181. Pippen R. Anaphylactoid reaction after chymacort ointment. Br Med J 5496 (1966) 1172
182. Scala E., Giani M., Pirrotta L., Guerra E.C., De Pità O., and Puddu P. Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin. Int J Dermatol 40 (2001) 603-604
183. Romano A., Viola M., Di Fonso M., Rosaria Perrone M., Gaeta F., and Andriolo M. Anaphylaxis to streptomycin. Allergy 57 (2002) 1087-1088
184. De Castro Martinez F.J., Ruiz F.J., Tornero P., De Barrio M., and Prieto A. Systemic contact dermatitis due to fusidic acid. Contact Dermatitis 54 (2006) 169
185. Knowles S., Choudhury T., and Shear N.H. Metronidazole hypersensitivity. Ann Pharmacother 28 (1994) 325-326
186. Tkach J.R. Allergic contact urticaria to benzoyl peroxide. Cutis 29 (1982) 187-188
187. Katsarou A., Armenaka M., Ale I., Koufou V., and Kalogeromitros D. Frequency of immediate reactions to the European standard series. Contact Dermatitis 41 (1999) 276-279
188. Liphshitz I., and Loewenstein A. Anaphylactic reaction following application of chloramphenicol eye ointment. Br J Ophthalmol 75 (1991) 64
189. Grob J.J., Pommier G., Robaglia A., Collet-Villette A.M., and Boneradi J.J. Contact urticaria from rifamycin. Contact Dermatitis 16 (1987) 284-285
190. Schulze I.-S., and Wollina U. [Type-1-allergy with shock fragments due to metronidazole]. Aktuelle Dermatologie 31 (2005) 157-159
191. Duve S., Worret W., and Hofmann H. The baboon syndrome: a manifestation of haematogenous contact-type dermatitis. Acta Derm Venereol 74 (2004) 480-481
192. Andersen K.E., Hjorth N., and Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Dermatitis 10 (1984) 97-100
193. Hausermann P., Harr T.h., and Bircher A.H. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?. Contact Dermatitis 51 (2004) 297-310
194. de Groot A.C. Patch testing: test concentrations and vehicles for 3700 chemicals. 2nd ed. (1994), Elsevier, New York
195. Smack D.P., Harrington A.C., Dunn C., Howard R.S., Szkutnik A.J., Krivda S.J., et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA 276 (1996) 972-977
196. Renner R., and Wollina U. Contact sensitization in patients with leg ulcers and/or leg eczema: comparison between centers. Lower Extrem Wounds 1 (2002) 251-255